1 Min Read
Nov 8 (Reuters) - BioCryst Pharmaceuticals Inc
* Files for mixed shelf of up to $200 million - SEC filing Source text: (bit.ly/2m4wZHE) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.